Treatment

Grafalon 20 mg/ml concentrato per soluzione per infusione clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedPhase II and Phase III (Integrated)
Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients: a Spanish Multicenter, Randomized, Controlled Parallel-group Trial: The TRAINING Study
This study, called 'The TRAINING Study', looks at whether treating early, minor issues (borderline lesions) in transplanted kidneys helps them work better long-term. Researchers compare a specific treatment to standard care in people who have had a kidney transplant and are at low risk of rejection.
For: To analyze whether the anti-rejection treatment of borderline lesions can modify the expression and · klotho levels, as well as proinflammatory cytokines that regulate klotho expression at both · years post-transplant., Know in a controlled and randomized clinical trial, carried out in low-risk patients
Spain